Pyramid® 5 + Presponse® SQ Approved for Extended BVD

Jamie JohansenAgribusiness, Animal Health, Beef, Boehringer Ingelheim, Cattle, Dairy, Disease

BIVI_288_logo.212131245_stdPyramid® 5 + Presponse® SQ from Boehringer Ingelheim Vetmedica, Inc. (BIVI) recently received a new label claim for protection against respiratory disease caused by bovine viral diarrhea (BVD) Type 1b for at least 217 days. BVD Type 1b is the most common subtype of BVD found in persistently infected (PI) calves. This new claim reinforces the elite BVD protection offered by BIVI’s modified-live virus (MLV) vaccine portfolio.

“PI calves, while small in number, are one of the most common sources of BVD spread as they shed the virus to susceptible calves,” says Dr. Doug Ensley, Professional Services Veterinarian, Boehringer Ingelheim Vetmedica, Inc. “This new claim helps producers protect against the BVD subtype most commonly found in these calves, so they know they are getting the best protection for their herd.”

With PYRAMID 5 + PRESPONSE SQ, two leading respiratory vaccines are provided in the convenience of one dose, protecting against disease caused by BVD types 1 and 2, infectious bovine rhinotrachetitis (IBR), parainfluenza 3 (PI3), bovine respiratory syncytial virus (BRSV), and Mannheimia haemolytica.

“BVD prevention remains a key issue for cattle producers in their aim to keep their herds healthy. By vaccinating calves at all stages with PYRAMID 5 + PRESPONSE SQ, producers can be assured their cattle are protected against BVD and other causes of respiratory disease,” says Dr. Ensley.

For producers looking to further prevent the negative impact of PI calves, BIVI offers Express® FP for vaccination of cows. EXPRESS FP is labeled to prevent calves persistently infected with BVD when cows are vaccinated according to label directions.